Hos patienter med kompenseret leversygdom ledsages disse stigninger i serum- ALAT generelt ikke af stigninger i serum- bilirubin eller hepatisk inkompensation.
In patients with compensated liver disease, these increases in serum ALT are generally not accompanied by an increase in serum bilirubin concentrations or hepatic decompensation.